Baird Net Debt from 2010 to 2024

BDMD Stock   2.40  0.05  2.04%   
Baird Medical's Net Debt is increasing over the years with slightly volatile fluctuation. Net Debt is expected to dwindle to about 6.1 M. Net Debt is the total debt of Baird Medical Investment minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals
 
Net Debt  
First Reported
2010-12-31
Previous Quarter
6.7 M
Current Value
6.1 M
Quarterly Volatility
668 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Baird Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Baird Medical's main balance sheet or income statement drivers, such as Tax Provision of 1.6 M, Interest Income of 1.5 K or Interest Expense of 271 K, as well as many indicators such as . Baird financial statements analysis is a perfect complement when working with Baird Medical Valuation or Volatility modules.
  
Check out the analysis of Baird Medical Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Baird Medical Investment is a strong investment it is important to analyze Baird Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Baird Medical's future performance. For an informed investment choice regarding Baird Stock, refer to the following important reports:
Check out the analysis of Baird Medical Correlation against competitors.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baird Medical. If investors know Baird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baird Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Baird Medical Investment is measured differently than its book value, which is the value of Baird that is recorded on the company's balance sheet. Investors also form their own opinion of Baird Medical's value that differs from its market value or its book value, called intrinsic value, which is Baird Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baird Medical's market value can be influenced by many factors that don't directly affect Baird Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baird Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baird Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baird Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.